1st Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$950,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Patient access and maintain six protected class status of medicines to treat serious mental illness under Medicare Part D; Inflation Reduction Act of 2022 implementation; Medicaid Drug Rebate Program proposed rule Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL —
PETER NORMAN —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 2163/S. 464 the Safe Step Act; Policies impacting pharmaceutical development, reimbursement, and patient access and cost; Awareness of need for transparency and patient access within the 340B program; H.R. 2882 Further Consolidated Appropriations Act, 2024; Labor, Health and Human Services, Education Appropriations, 2025; Commerce, Justice, Science, and Related Agencies Appropriations, 2025; Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill, 2025; Support FDA efficiency reforms

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS —
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL —
PETER NORMAN —

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP)

Bills named: S. 464 (118th), H.R. 2163 (118th), H.R. 2882 (118th)

Alcohol and Drug Abuse ALC

Expand funding and flexibility to address all substance use disorders;

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS —
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Executive Office of the President (EOP); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.